Target intelligence / Profile preview

Probable ATP-dependent RNA helicase DExD-box helicase 52 (DDX52)

Target
DDX52
Molecular classification
Enzyme (ATP-dependent RNA helicase), DEAD-box protein family
01

Overview

DDX52 is a member of the DEAD-box family of RNA helicases, characterized by two conserved domains responsible for ATP binding and RNA remodeling activities. It plays a fundamental role in ribosome biogenesis by promoting the processing and maturation of precursor rRNA, particularly the 47S pre-rRNA, leading to protein synthesis and cell growth. DDX52 is rapidly upregulated during wound healing and tissue regeneration in vertebrates and is essential for post-embryonic development and organ growth. Deficiency or suppression of DDX52 results in stunted growth and defective regeneration, while its overexpression can promote growth in early developmental stages. Human DDX52 is associated with several diseases, and the DEAD-box helicase family, in general, is linked to cancer and viral replication, highlighting their potential as therapeutic targets.

Other names
DDX52ROK1HUSSY-19DEAD box protein 52ATP-dependent RNA helicase ROK1-likeHUSSY19DEAD-box helicase 52DEAD (Asp-Glu-Ala-Asp) box polypeptide 52
02

Mechanism of action

Not established for direct inhibitors. General mechanism involves inhibition of rRNA synthesis and RNA transcription (as seen with Actinomycin D, which inhibits RNA polymerase I and thus rRNA synthesis)

03

Biological functions

Ribosome biogenesisrRNA synthesis and processingRNA binding and remodelingRegulation of mRNA transcriptionControl of cell growth and regeneration
04

Disease associations

CancerViral infectionChromosome 17q12 deletion syndromePolycystic kidney disease(Potential roles in other diseases, but not clearly established)
05

Safety considerations

Inhibition of DDX52 or its pathway can lead to defective growth, impaired regeneration, and developmental abnormalities as shown in animal modelsGlobal suppression of rRNA synthesis has cytotoxic effects, limiting therapeutic window
06

Biomarkers

DDX52 mRNA or protein levels may serve as a biomarker for ribosome biogenesis activity and regenerative growth processes, particularly in experimental modelsNo clinically validated biomarkers are reported

Beyond the preview

Go deeper on Probable ATP-dependent RNA helicase DExD-box helicase 52 (DDX52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable ATP-dependent RNA helicase DExD-box helicase 52 (DDX52).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call